- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Protective AIDS Mutation: A Double-Edged Sword?
27 June 1997 (All day)
A genetic mutation that can delay the onset of AIDS in people infected with HIV may hasten death after symptoms of the disease appear. A report in tomorrow's Lancet suggests that, once HIV infection progresses to AIDS, patients with a mutated copy of the gene for what's called the CCR5 receptor die 6 months sooner, on average, than those with good copies. Researchers are surprised by the finding, which must be corroborated by larger studies.
For the HIV virus to get into a cell and replicate, it must latch onto certain proteins that stud the surface of immune cells. Last year, researchers identified one of these footholds, a receptor called CCR5. They also discovered that a few people, who lack this receptor because both copies of the gene coding for it were bad, seemed to resist infection with HIV. Another study (Science, 27 September 1996, p. 1856) revealed that people with a single mutated copy of the receptor gene tended to live without symptoms of AIDS for years longer than those with both copies intact.
But a mutation may actually be a mixed blessing, argues Peter Garred of the Tissue-Typing Laboratory at the Rigshospitalet in Copenhagen, Denmark. For 11 years he and his colleagues have been tracking the health of 99 gay men infected with HIV. So far, they have examined the DNA of 56 who have died, looking for mutations in the CCR5 gene. The 45 men who carried normal copies lived up to 6.5 years past their diagnosis with AIDS, although the average survival was 17 months. Those with a mutation in one copy of the gene faced much bleaker prospects: The longest any of these 11 men survived after diagnosis was 20 months and the average was just 11 months.
The findings are "provocative," says Michael Dean of the National Cancer Institute. Dean points out that after the emergence of virulent strains that circumvent CCR5—one of the steps that heralds the arrival of AIDS symptoms—mutations on the gene for that receptor should have no effect on life expectancy. Garred speculates, however, that the faulty receptor could somehow be hampering the immune system, perhaps making patients more vulnerable to virulent HIV strains.